» Articles » PMID: 25358021

Assessment of Five Different Guideline Indication Criteria for Spirometry, Including Modified GOLD Criteria, in Order to Detect COPD: Data from 5,315 Subjects in the PLATINO Study

Abstract

Background: Spirometry is the gold standard for diagnosing chronic obstructive pulmonary disease (COPD). Although there are a number of different guideline criteria for deciding who should be selected for spirometric screening, to date it is not known which criteria are the best based on sensitivity and specificity.

Aims: Firstly, to evaluate the proportion of subjects in the PLATINO Study that would be recommended for spirometry testing according to Global initiative for Obstructive Lung Disease (GOLD)-modified, American College of Chest Physicians (ACCP), National Lung Health Education Program (NLHEP), GOLD and American Thoracic Society/European Respiratory Society (ATS/ERS) criteria. Secondly, we aimed to compare the sensitivity, specificity, and positive predictive and negative predictive values, of these five different criteria.

Methods: Data from the PLATINO study included information on respiratory symptoms, smoking and previous spirometry testing. The GOLD-modified spirometry indication criteria are based on three positive answers out of five questions: the presence of cough, phlegm in the morning, dyspnoea, age over 40 years and smoking status.

Results: Data from 5,315 subjects were reviewed. Fewer people had an indication for spirometry (41.3%) according to the GOLD-modified criteria, and more people had an indication for spirometry (80.4%) by the GOLD and ATS/ERS criteria. A low percentage had previously had spirometry performed: GOLD-modified (14.5%); ACCP (13.2%); NLHEP (12.6%); and GOLD and ATS/ERS (12.3%). The GOLD-modified criteria showed the least sensitivity (54.9) and the highest specificity (61.0) for detecting COPD, whereas GOLD and ATS/ERS criteria showed the highest sensitivity (87.9) and the least specificity (20.8).

Conclusion: There is a considerable difference in the indication for spirometry according to the five different guideline criteria. The GOLD-modified criteria recruit less people with the greatest sum of sensitivity and specificity.

Citing Articles

Using flexible methods to determine risk factors for ventilator-associated pneumonia in the Netherlands.

van der Kooi T, Boshuizen H, Wille J, De Greeff S, van Dissel J, Schoffelen A PLoS One. 2019; 14(6):e0218372.

PMID: 31220122 PMC: 6586305. DOI: 10.1371/journal.pone.0218372.


Chronic Obstructive Pulmonary Disease in Latin America.

Perez-Padilla R, Menezes A Ann Glob Health. 2019; 85(1).

PMID: 30741508 PMC: 7052319. DOI: 10.5334/aogh.2418.


Spirometry in Asthma Care: A Review of the Trends and Challenges in Pediatric Practice.

Ayuk A, Uwaezuoke S, Ndukwu C, Ndu I, Iloh K, Okoli C Clin Med Insights Pediatr. 2017; 11:1179556517720675.

PMID: 28781518 PMC: 5521334. DOI: 10.1177/1179556517720675.


Respiratory illness and air pollution from the steel industry: the case of Piquiá de Baixo, Brazil (Preliminary report).

Valenti C, Pozzi P, Busia A, Mazza R, Bossi P, De Marco C Multidiscip Respir Med. 2016; 11:41.

PMID: 27833748 PMC: 5101733. DOI: 10.1186/s40248-016-0077-9.


Correlation of the Ratio of Upper Third to Lower Third Circumferences of the Chest with Obstructive Pattern in Spirometry.

Alavi Foumani A, Amin A, Tangestani Nejad A, Kazemnejad E, Salamat F, Massahnia S Tanaffos. 2016; 14(4):222-6.

PMID: 27114722 PMC: 4841987.


References
1.
Enright P, Crapo R . Controversies in the use of spirometry for early recognition and diagnosis of chronic obstructive pulmonary disease in cigarette smokers. Clin Chest Med. 2001; 21(4):645-52. DOI: 10.1016/s0272-5231(05)70174-x. View

2.
. Strategies in preserving lung health and preventing COPD and associated diseases. The National Lung Health Education Program (NLHEP). Chest. 1998; 113(2 Suppl):123S-163S. DOI: 10.1378/chest.113.2_supplement.123s. View

3.
Qaseem A, Snow V, Shekelle P, Sherif K, Wilt T, Weinberger S . Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007; 147(9):633-8. View

4.
Soriano J, Miravitlles M, Garcia-Rio F, Munoz L, Sanchez G, Sobradillo V . Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants. Prim Care Respir J. 2012; 21(2):187-93. PMC: 6547920. DOI: 10.4104/pcrj.2012.00027. View

5.
Celli B, MacNee W . Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23(6):932-46. DOI: 10.1183/09031936.04.00014304. View